Celltrion
068270.KS
#825
Rank
S$31.66 B
Marketcap
$145.47
Share price
0.22%
Change (1 day)
-18.41%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): S$0.62 Billion

According to Celltrion 's latest financial reports the company's current earnings are S$2.58 Billion. a decrease over its 2023 earnings that were of S$0.67 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 S$0.61 B-8.8%
2023 S$0.67 B6.8%
2022 S$0.63 B-21.85%
2021 S$0.80 B10.25%
2020 S$0.73 B65.16%
2019 S$0.44 B16.64%
2018 S$0.38 B-33.89%
2017 S$0.57 B106.53%
2016 S$0.27 B25.57%
2015 S$0.22 B-6.54%
2014 S$0.23 B47.36%
2013 S$0.16 B-33.63%
2012 S$0.24 B
2010 S$0.12 B72.84%
2009 S$72.81 M260.54%
2008 S$20.19 M